219 related articles for article (PubMed ID: 15149341)
1. Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease.
Agarwal R; Vasavada N; Sachs NG; Chase S
Kidney Int; 2004 Jun; 65(6):2279-89. PubMed ID: 15149341
[TBL] [Abstract][Full Text] [Related]
2. Sodium ferric gluconate causes oxidative stress but not acute renal injury in patients with chronic kidney disease: a pilot study.
Leehey DJ; Palubiak DJ; Chebrolu S; Agarwal R
Nephrol Dial Transplant; 2005 Jan; 20(1):135-40. PubMed ID: 15522899
[TBL] [Abstract][Full Text] [Related]
3. Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis.
Pai AB; Boyd AV; McQuade CR; Harford A; Norenberg JP; Zager PG
Pharmacotherapy; 2007 Mar; 27(3):343-50. PubMed ID: 17316146
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress in hemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress.
Swarnalatha G; Ram R; Neela P; Naidu MU; Dakshina Murty KV
Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):852-8. PubMed ID: 20814119
[TBL] [Abstract][Full Text] [Related]
5. Acute injury with intravenous iron and concerns regarding long-term safety.
Bishu K; Agarwal R
Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S19-23. PubMed ID: 17699372
[TBL] [Abstract][Full Text] [Related]
6. The effects of iron dextran on the oxidative stress in cardiovascular tissues of rats with chronic renal failure.
Lim CS; Vaziri ND
Kidney Int; 2004 May; 65(5):1802-9. PubMed ID: 15086920
[TBL] [Abstract][Full Text] [Related]
7. Effect of intravenous vitamin C on cytokine activation and oxidative stress in end-stage renal disease patients receiving intravenous iron sucrose.
Conner TA; McQuade C; Olp J; Pai AB
Biometals; 2012 Oct; 25(5):961-9. PubMed ID: 22706571
[TBL] [Abstract][Full Text] [Related]
8. Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockade.
Agarwal R
Am J Physiol Renal Physiol; 2003 Apr; 284(4):F863-9. PubMed ID: 12505865
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of N-acetylcysteine on experimental chronic lead nephrotoxicity in immature female rats.
Wang L; Wang Z; Liu J
Hum Exp Toxicol; 2010 Jul; 29(7):581-91. PubMed ID: 20097726
[TBL] [Abstract][Full Text] [Related]
10. The effect of serum albumin level on iron-induced oxidative stress in chronic renal failure patients.
Sezer MT; Akin H; Demir M; Erturk J; Aydin ZD; Savik E; Tunc N
J Nephrol; 2007; 20(2):196-203. PubMed ID: 17514624
[TBL] [Abstract][Full Text] [Related]
11. Effects of intravenous polymaltose iron on oxidant stress and non-transferrin-bound iron in hemodialysis patients.
Driss F; Vrtovsnik F; Katsahian S; Michel C; Baron G; Kolta A; Sedrati N; Mentré F; Mignon F; Cabantchik I; Grandchamp B
Nephron Clin Pract; 2005; 99(3):c63-7. PubMed ID: 15640610
[TBL] [Abstract][Full Text] [Related]
12. The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients.
Cavdar C; Temiz A; Yeniçerioğlu Y; Calişkan S; Celik A; Sifil A; Onvural B; Camsari T
Scand J Urol Nephrol; 2003; 37(1):77-82. PubMed ID: 12745750
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of N-acetylcysteine on experimental chronic cadmium nephrotoxicity in immature female rats.
Wang L; Chen D; Cao J; Liu Z
Hum Exp Toxicol; 2009 Apr; 28(4):221-9. PubMed ID: 19734274
[TBL] [Abstract][Full Text] [Related]
14. Iron and oxidative stress in renal insufficiency.
Lim CS; Vaziri ND
Am J Nephrol; 2004; 24(6):569-75. PubMed ID: 15550752
[TBL] [Abstract][Full Text] [Related]
15. Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat.
Chatterjee PK; Cuzzocrea S; Brown PA; Zacharowski K; Stewart KN; Mota-Filipe H; Thiemermann C
Kidney Int; 2000 Aug; 58(2):658-73. PubMed ID: 10916089
[TBL] [Abstract][Full Text] [Related]
16. N-acetylcysteine as a potential strategy to attenuate the oxidative stress induced by uremic serum in the vascular system.
Rodrigues SD; França KC; Dallin FT; Fujihara CK; Nascimento AJ; Pecoits-Filho R; Nakao LS
Life Sci; 2015 Jan; 121():110-6. PubMed ID: 25500303
[TBL] [Abstract][Full Text] [Related]
17. Preventive effect of specific antioxidant on oxidative renal cell injury associated with renal crystal formation.
Fishman AI; Green D; Lynch A; Choudhury M; Eshghi M; Konno S
Urology; 2013 Aug; 82(2):489.e1-7. PubMed ID: 23796398
[TBL] [Abstract][Full Text] [Related]
18. N-acetylcysteine pretreatment ameliorates mercuric chloride-induced oxidative renal damage in rats.
Ekor M; Adesanoye OA; Farombi EO
Afr J Med Med Sci; 2010 Dec; 39 Suppl():153-60. PubMed ID: 22416658
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of oxidative stress after repeated intravenous iron supplementation.
Mimić-Oka J; Savić-Radojević A; Pljesa-Ercegovac M; Opacić M; Simić T; Dimković N; Simić DV
Ren Fail; 2005; 27(3):345-51. PubMed ID: 15957553
[TBL] [Abstract][Full Text] [Related]
20. Proinflammatory effects of iron sucrose in chronic kidney disease.
Agarwal R
Kidney Int; 2006 Apr; 69(7):1259-63. PubMed ID: 16609688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
